Found: 5
Select item for more details and to access through your institution.
Reporting of meta-analyses of randomized controlled trials with a focus on drug safety: An empirical assessment.
- Published in:
- Clinical Trials, 2013, v. 10, n. 3, p. 389, doi. 10.1177/1740774513479467
- By:
- Publication type:
- Article
A REVIEW OF RECENT FEDERAL LEGISLATIVE AND POLICY INITIATIVES TO ENHANCE THE DEVELOPMENT AND EVALUATION OF HIGH VALUE DRUGS IN THE UNITED STATES.
- Published in:
- DePaul Journal of Health Care Law, 2013, v. 14, n. 3, p. 503
- By:
- Publication type:
- Article
Evaluation of FDA safety-related drug label changes in 2010.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2013, v. 22, n. 3, p. 302, doi. 10.1002/pds.3395
- By:
- Publication type:
- Article
Post-market drug safety evidence sources: an analysis of FDA drug safety communications.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2012, v. 21, n. 10, p. 1134, doi. 10.1002/pds.3317
- By:
- Publication type:
- Article
Secondary use of randomized controlled trials to evaluate drug safety: a review of methodological considerations.
- Published in:
- Clinical Trials, 2011, v. 8, n. 5, p. 559, doi. 10.1177/1740774511419165
- By:
- Publication type:
- Article